Comparison between Satol Chemicals IPO and Studio LSD IPO.
Satol Chemicals IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Studio LSD IPO is a SME Bookbuilding proposed to list at NSE SME.
| Satol Chemicals IPO | Studio LSD IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Finshore Management Services Ltd. | Corpwis Advisors Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Purva Sharegistry (India) Pvt.Ltd. |
| Market Maker | Rikhav Securities Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Satol Chemicals IPO is up to ₹30.24 Cr whereas the issue size of the Studio LSD IPO is up to ₹70.53 Cr. The final issue price of Satol Chemicals IPO is ₹72.00 per share and of Studio LSD IPO is ₹54.00 per share.
| Satol Chemicals IPO | Studio LSD IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹51.00 per share | |
| Issue Price (Upper) | ₹54.00 per share | |
| Issue Price (Final) | ₹72.00 per share | ₹54.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 2000 shares |
| Fresh Issue Size | 42,00,000 shares | 1,03,12,000 shares |
| Fresh Issue Size (Amount) | up to ₹30.24 Cr | up to ₹55.68 Cr |
| OFS Issue Size | 0 shares | 27,50,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹14.85 Cr |
| Issue Size Total | 42,00,000 shares | 1,30,62,000 shares |
| Issue Size Total (Amount) | up to ₹30.24 Cr | up to ₹70.53 Cr |
Satol Chemicals IPO opens on , while Studio LSD IPO opens on Aug 18, 2025. The closing date of Satol Chemicals IPO and Studio LSD IPO is , and Aug 20, 2025, respectively.
| Satol Chemicals IPO | Studio LSD IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 18, 2025 | |
| Issue Close | Aug 20, 2025 | |
| Basis Of Allotment (Tentative) | Aug 21, 2025 | |
| Initiation of Refunds (Tentative) | Aug 22, 2025 | |
| Credit of Share (Tentative) | Aug 22, 2025 | |
| Listing date (Tentative) | Aug 25, 2025 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Satol Chemicals IPO P/E ratio is 14.55, as compared to Studio LSD IPO P/E ratio of 18.92.
| Satol Chemicals IPO | Studio LSD IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Standalone)
| Company Financials (Restated Consolidated)Studio LSD Ltd.'s revenue increased by 2% and profit after tax (PAT) rose by 7% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.97 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.63 | 73.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.55 | 18.92 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹110.56 Cr. | ₹280.22 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 106% | 53.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 47.07% | 57.29% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.95 | ₹2.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 69.28% | 53.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Satol Chemicals IPO Retail Individual Investors (RII) are offered while in Studio LSD IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Satol Chemicals IPO and 1,32,000 shares in Studio LSD IPO.
| Satol Chemicals IPO | Studio LSD IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 2,11,200 shares | 6,88,000 shares |
| QIB | 1,32,000 shares | |
| NII | 51,72,000 shares | |
| RII | 77,58,000 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 1,30,62,000 shares |
Satol Chemicals IPO subscribed in total, whereas Studio LSD IPO subscribed 3.23x.
| Satol Chemicals IPO | Studio LSD IPO | |
|---|---|---|
| QIB (times) | 1.00x | |
| NII (times) | 1.25x | |
| Big NII (times) | 0.96x | |
| Small NII (times) | 1.84x | |
| RII (times) | 4.58x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 3.23x |
